Bioventus BVS U.S. Segment — Adjusted other segment expense

Similar metrics at other companies

GPORReportable Segments — Other segment expenses

$2.3M+2,833%

FLUTU.S. — Reportable segment Adjusted EBITDA

$119M-70.3%

XMTRUS — Segment Adjusted Operating Expense

$53.05M+17.7%

SUNBU.K. — Adjusted Segment Operating Income (Expense)

$14M-6.7%

ANGIU.S. — Segment Expenses

$187.38M-1.9%

KDPU.S. Coffee — Other segment expense

$46M+4,500%

FAQ

What is Bioventus's U.S. segment — adjusted other segment expense?

Bioventus (BVS) reported U.S. segment — adjusted other segment expense of -$295K in Q2 2026.

How has Bioventus's U.S. segment — adjusted other segment expense changed year-over-year?

Bioventus's U.S. segment — adjusted other segment expense decreased by 180.6% year-over-year, from $366K to -$295K.

What is the long-term trend for Bioventus's U.S. segment — adjusted other segment expense?

Over 3 years (2022 to 2025), Bioventus's U.S. segment — adjusted other segment expense has grown at a 13.9% compound annual growth rate (CAGR), from -$1.05M to $1.55M.

What does U.S. segment — adjusted other segment expense mean?

This metric captures miscellaneous adjusted operating expenses related to the U.S. segment that do not fall under standard cost of sales, selling, marketing, or administrative categories. It provides a comprehensive view of the total operational cost structure unique to the domestic business.